Therapeutic molecules that bind to LAG3 and PD1 Grant US-11951172-B2 United States of America 09 Apr 2024
BINDING MOLECULES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL Application EP-4342912-A2 European Patent Office 27 Mar 2024
Multispecific antibodies against CD40 and CD137 Grant US-11939388-B2 United States of America 26 Mar 2024
CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND A CHEMOTHERAPEUTIC Application WO-2024042105-A1 World Intellectual Property Organisation (WIPO) 29 Feb 2024
COMBINATION CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND PD-1/PD-L1… Application WO-2024042104-A1 World Intellectual Property Organisation (WIPO) 29 Feb 2024
NOVEL DOSAGES OF ANTI-CD137 ANTIBODY Application WO-2024023118-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2024
NOVEL DOSAGES OF ANTI-CD137 ANTIBODY Application WO-2024023120-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2024
Anti-human 4-1BB antibodies and uses thereof Grant US-11859004-B2 United States of America 02 Jan 2024
Single domain antibodies to programmed cell death (PD-1) Grant US-11814429-B2 United States of America 14 Nov 2023
NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1 Application EP-4249064-A2 European Patent Office 27 Sep 2023
Processes for generating TIL products enriched for tumor antigen-specific T-cells Grant US-11713446-B2 United States of America 01 Aug 2023
Binding molecules that bind CD137 and PD-L1 Grant US-11685786-B2 United States of America 27 Jun 2023
Combination therapy using T cell redirection antigen binding molecule against cell having… Grant US-11660340-B2 United States of America 30 May 2023
Single domain antibodies to programmed cell death protein 1 (PD-1) Grant US-11591398-B2 United States of America 28 Feb 2023
4-1BB antibody and preparation method and use thereof Grant US-11555077-B2 United States of America 17 Jan 2023
T cell-redirected antigen-binding molecule for cells having immunosuppression function Grant US-11505605-B2 United States of America 22 Nov 2022
Multispecific antibodies against CD40 and CD137 Grant US-11440966-B2 United States of America 13 Sep 2022
Anti-CD137 antibodies and methods of use thereof Grant US-11242385-B2 United States of America 08 Feb 2022
MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB Application WO-2021245240-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
4-1BB ANTIBODY AND PREPARATION METHOD AND USE THEREOF Application EP-3708582-A4 European Patent Office 01 Dec 2021
Anti-CD137 antibodies and methods of use thereof Grant US-11098117-B2 United States of America 24 Aug 2021
Methods of producing multispecific antibodies against CD40 and CD137 Grant US-11091557-B2 United States of America 17 Aug 2021
Multispecific antibodies against CD40 and CD137 Grant US-11084882-B2 United States of America 10 Aug 2021
Novel fusion proteins specific for CD137 and PD-L1 Application KR-20210040103-A Republic of Korea 12 Apr 2021
Anti-human 4-1BB antibodies and uses thereof Grant US-10919972-B2 United States of America 16 Feb 2021
Methods for isolating and proliferating autologous cancer antigen-specific CD8+ T cells Grant US-10801011-B2 United States of America 13 Oct 2020
Anti-human 4-1BB antibodies and uses thereof Grant US-10774151-B2 United States of America 15 Sep 2020
NOVEL FUSION PROTEINS SPECIFIC FOR CD137 AND GPC3 Application WO-2020173897-A1 World Intellectual Property Organisation (WIPO) 03 Sep 2020
Agonist antibodies that bind human CD137 and uses thereof Grant US-10716851-B2 United States of America 21 Jul 2020
ANTI-CD137 ANTIBODY AND USES THEREOF Application WO-2020077635-A1 World Intellectual Property Organisation (WIPO) 23 Apr 2020
Methods for isolating and proliferating autologous cancer antigen-specific CD8+T cells Grant US-10570371-B2 United States of America 25 Feb 2020
NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1 Application WO-2020025659-A1 World Intellectual Property Organisation (WIPO) 06 Feb 2020
ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137 Application WO-2020011964-A1 World Intellectual Property Organisation (WIPO) 16 Jan 2020
MESOTHELIN AND CD137 BINDING MOLECULES Application WO-2020011976-A1 World Intellectual Property Organisation (WIPO) 16 Jan 2020
Agonist antibodies that bind human CD137 and uses thereof Grant US-10434175-B2 United States of America 08 Oct 2019
Agonist antibodies that bind human CD137 and uses thereof Application US-10350292-B1 United States of America 16 Jul 2019
Single Domain Antibodies that Bind to CD137 Application WO-2019092451-A1 World Intellectual Property Organisation (WIPO) 16 May 2019
MOLECULES THAT BIND TO CD137 AND PSMA Application WO-2019092452-A1 World Intellectual Property Organisation (WIPO) 16 May 2019
Agonist antibodies that bind human CD137 and uses thereof Application US-10279040-B1 United States of America 07 May 2019
Agonist antibodies that bind human CD137 and uses thereof Application US-10279039-B2 United States of America 07 May 2019
Agonist antibodies that bind human CD137 and uses thereof Grant US-10279038-B2 United States of America 07 May 2019
ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF Application WO-2019072870-A1 World Intellectual Property Organisation (WIPO) 18 Apr 2019
FULLY HUMAN ANTIBODY AGAINST HUMAN CD137 AND USE THEREOF Application EP-3354661-A4 European Patent Office 03 Apr 2019
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF Application WO-2019014328-A3 World Intellectual Property Organisation (WIPO) 21 Feb 2019
ANTI-CD137 ANTIBODIES Application WO-2019027754-A1 World Intellectual Property Organisation (WIPO) 07 Feb 2019
Anti-human 4-1BB antibodies and uses thereof Application US-10174122-B2 United States of America 08 Jan 2019
Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist Grant US-10023649-B2 United States of America 17 Jul 2018
PROTEINS SPECIFIC FOR CD137 Application WO-2018087108-A1 World Intellectual Property Organisation (WIPO) 17 May 2018
BINDING MOLECULES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL Application WO-2018056821-A1 World Intellectual Property Organisation (WIPO) 29 Mar 2018
ANTI-4-1BB ANTIBODIES AND THEIR USES Application WO-2017205745-A1 World Intellectual Property Organisation (WIPO) 30 Nov 2017
COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER Application EP-3145956-A1 European Patent Office 29 Mar 2017